{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-23-000104","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.224415+00:00","generated_at":"2026-06-12T09:45:30.561402+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Stryker Q2 2023: Net sales +11.2% to $5.0B; adj. EPS $2.54; raises FY organic growth outlook to 9.5%-10.5%","bullets":["Net sales $5.0B, +11.2% reported, +11.9% organic; adj. EPS $2.54 (+12.9%).","MedSurg & Neurotechnology $2.9B (+12.9% organic); Orthopaedics & Spine $2.1B (+10.6% organic).","Reported op margin 19.3%; adjusted op margin 24.3% (up 60bps).","FY2023 organic sales growth guidance raised to 9.5%-10.5%; adj EPS guidance $10.25-$10.45."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-23-000104","json":"https://secwatch.observer/filing/0000310764-23-000104.json","markdown":"https://secwatch.observer/filing/0000310764-23-000104.md","text":"https://secwatch.observer/filing/0000310764-23-000104.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076423000104/0000310764-23-000104-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076423000104/syk-20230803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T09:45:30.561402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0cbcc5eecaafe42cf12f23fdb596a1825317b766","claim":"STRYKER CORP reported full year 2023 results: EPS $10.25 to $10.45. Guidance raised.","evidence_excerpt":"we now expect adjusted net earnings per diluted share (2) to be in the range of $10.25 to $10.45.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310764/000031076423000104/0000310764-23-000104-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2023"},{"label":"EPS","value":"$10.25 to $10.45"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"bc570e05beeb11378f1adb95b5753d6264b93de0","claim":"STRYKER CORP reported second quarter 2023 results: revenue $5.0 billion.","evidence_excerpt":"Reported net earnings of $738 million increased 12.5% in the quarter. Reported net earnings per diluted share of $1.93 increased 12.2% in the quarter.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310764/000031076423000104/0000310764-23-000104-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter 2023"},{"label":"Revenue","value":"$5.0 billion"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"bc570e05beeb11378f1adb95b5753d6264b93de0","claim":"STRYKER CORP reported second quarter 2023 results: revenue $5.0 billion.","evidence_excerpt":"Reported net sales increased 11.2% to $5.0 billion","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310764/000031076423000104/0000310764-23-000104-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter 2023"},{"label":"Revenue","value":"$5.0 billion"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}